Concepedia

Ibrahim Turkoz

IT

Statistics

Publications

56

Citations

2.5K

H-Index

25

Active since

2004

Affiliations

Janssen (United States)(Current)

Janssen Scientific Affairs (United States)

Johnson & Johnson (United States)

Janssen (Belgium)

University of California, Los Angeles

Ibrahim Turkoz is an author at Janssen (United States) specializing in psychopharmacology, pharmacotherapy, and psychiatry.

ORCID

Publications per year

2004–2025

56

Publications

56

Effects of Behavioral Therapy on Weight Loss in Overweight and Obese Patients With Schizophrenia or Schizoaffective Disorder

Jaspreet S. Brar, Rohan Ganguli, Gahan Pandina et al. · The Journal of Clinical Psychiatry · 2005 · 179 citations

, , +17

A randomized, double‐blind, placebo‐controlled study of maintenance treatment with adjunctive risperidone long‐acting therapy in patients with bipolar I disorder who relapse frequently

Wayne Macfadden, Larry Alphs, J. Thomas Haskins et al. · Bipolar Disorders · 2009 · 178 citations

, , +17

Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation

Mark Hyman Rapaport, Georges M. Gharabawi, Carla M. Canuso et al. · Neuropsychopharmacology · 2006 · 147 citations

, , +14

Risperidone for Treatment-Refractory Major Depressive Disorder

Ramy Mahmoud, Gahan Pandina, Ibrahim Turkoz et al. · Annals of Internal Medicine · 2007 · 138 citations

, , +17

Acute Treatment of Psychotic Agitation

Glenn W. Currier, James C-Y Chou, David Feifel et al. · The Journal of Clinical Psychiatry · 2004 · 137 citations

, , +16

1–5 of 56